Cargando…

Sanitizer-associated systemic side effects in the era of COVID-19: a pharmacovigilance study

BACKGROUND: The practice of proper hand sanitization became of utmost importance and one of the best protective measures during the pandemic outbreak of COVID-19. However, misuse of disinfectants can be an overwhelming issue because of increasing demands, public panic, and unawareness, which can neg...

Descripción completa

Detalles Bibliográficos
Autores principales: Osama, Hasnaa, Abdelrahman, Mona A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188850/
https://www.ncbi.nlm.nih.gov/pubmed/35730011
http://dx.doi.org/10.1186/s43088-022-00263-7
_version_ 1784725465011847168
author Osama, Hasnaa
Abdelrahman, Mona A.
author_facet Osama, Hasnaa
Abdelrahman, Mona A.
author_sort Osama, Hasnaa
collection PubMed
description BACKGROUND: The practice of proper hand sanitization became of utmost importance and one of the best protective measures during the pandemic outbreak of COVID-19. However, misuse of disinfectants can be an overwhelming issue because of increasing demands, public panic, and unawareness, which can negatively affect human health and the environment. Therefore, we aimed to determine whether the outbreak was associated with increased reports of adverse events related to hand sanitizers through the data of adverse events reported to the pharmacovigilance database of the Food and Drug Administration Adverse Event Reporting System (FAERS). FAERS database was analyzed for hand sanitizer reports including alcohol-based and alcohol-free formulations. RESULTS: Adverse events reports associated with hand sanitizers increased significantly by 2020 with variable severity degrees, noting that most serious cases were reported with alcohol-based sanitizers. CONCLUSION: Based on data mining of the FAERS database, we claim that the increased reports associated with alcohol hand sanitizer use deserve attention. However, FAER’s database has some limitations, such as case duplication and lack of a control group. Hence, further monitoring with more robust sources of data sources is critically needed.
format Online
Article
Text
id pubmed-9188850
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-91888502022-06-17 Sanitizer-associated systemic side effects in the era of COVID-19: a pharmacovigilance study Osama, Hasnaa Abdelrahman, Mona A. Beni Suef Univ J Basic Appl Sci Research BACKGROUND: The practice of proper hand sanitization became of utmost importance and one of the best protective measures during the pandemic outbreak of COVID-19. However, misuse of disinfectants can be an overwhelming issue because of increasing demands, public panic, and unawareness, which can negatively affect human health and the environment. Therefore, we aimed to determine whether the outbreak was associated with increased reports of adverse events related to hand sanitizers through the data of adverse events reported to the pharmacovigilance database of the Food and Drug Administration Adverse Event Reporting System (FAERS). FAERS database was analyzed for hand sanitizer reports including alcohol-based and alcohol-free formulations. RESULTS: Adverse events reports associated with hand sanitizers increased significantly by 2020 with variable severity degrees, noting that most serious cases were reported with alcohol-based sanitizers. CONCLUSION: Based on data mining of the FAERS database, we claim that the increased reports associated with alcohol hand sanitizer use deserve attention. However, FAER’s database has some limitations, such as case duplication and lack of a control group. Hence, further monitoring with more robust sources of data sources is critically needed. Springer Berlin Heidelberg 2022-06-13 2022 /pmc/articles/PMC9188850/ /pubmed/35730011 http://dx.doi.org/10.1186/s43088-022-00263-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Osama, Hasnaa
Abdelrahman, Mona A.
Sanitizer-associated systemic side effects in the era of COVID-19: a pharmacovigilance study
title Sanitizer-associated systemic side effects in the era of COVID-19: a pharmacovigilance study
title_full Sanitizer-associated systemic side effects in the era of COVID-19: a pharmacovigilance study
title_fullStr Sanitizer-associated systemic side effects in the era of COVID-19: a pharmacovigilance study
title_full_unstemmed Sanitizer-associated systemic side effects in the era of COVID-19: a pharmacovigilance study
title_short Sanitizer-associated systemic side effects in the era of COVID-19: a pharmacovigilance study
title_sort sanitizer-associated systemic side effects in the era of covid-19: a pharmacovigilance study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188850/
https://www.ncbi.nlm.nih.gov/pubmed/35730011
http://dx.doi.org/10.1186/s43088-022-00263-7
work_keys_str_mv AT osamahasnaa sanitizerassociatedsystemicsideeffectsintheeraofcovid19apharmacovigilancestudy
AT abdelrahmanmonaa sanitizerassociatedsystemicsideeffectsintheeraofcovid19apharmacovigilancestudy